Stephen L. Holcombe
2020
In 2020, Stephen L. Holcombe earned a total compensation of $1.4M as President and Chief Executive Officer at vTv Therapeutics, a 68% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $225,000 |
|---|---|
| Option Awards | $716,373 |
| Salary | $450,000 |
| Other | $9,650 |
| Total | $1,401,023 |
Holcombe received $716.4K in option awards, accounting for 51% of the total pay in 2020.
Holcombe also received $225K in non-equity incentive plan, $450K in salary and $9.7K in other compensation.
Rankings
In 2020, Stephen L. Holcombe's compensation ranked 7,144th out of 13,090 executives tracked by ExecPay. In other words, Holcombe earned more than 45.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,144 out of 13,090 | 45th |
Division Manufacturing | 2,987 out of 5,620 | 47th |
Major group Chemicals And Allied Products | 1,205 out of 2,253 | 47th |
Industry group Drugs | 1,038 out of 1,953 | 47th |
Industry Pharmaceutical Preparations | 774 out of 1,458 | 47th |
Source: SEC filing on March 18, 2021.
Holcombe's colleagues
We found two more compensation records of executives who worked with Stephen L. Holcombe at vTv Therapeutics in 2020.
News
vTv Therapeutics CEO Deepa Prasad receives $3.3M in 2021
May 2, 2022
vTv Therapeutics CEO Stephen Holcombe's 2020 pay jumps 68% to $1.4M
March 18, 2021
vTv Therapeutics CEO Stephen Holcombe's 2019 pay jumps 81% to $833K
April 30, 2020
vTv Therapeutics CEO Stephen Holcombe's 2018 pay falls 63% to $459K
March 15, 2019